-
Product Insights
Crohn’s Disease (Regional Enteritis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Crohn’s Disease (Regional Enteritis) pipeline market research report provides comprehensive information on the therapeutics under development for Crohn's Disease (Regional Enteritis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Crohn's Disease...
-
Product Insights
Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Diarrhea is a contagious gastrointestinal infection occurring mostly due to unhygienic conditions. Diarrhea may be related to a viral or bacterial infection and is sometimes the result of food poisoning. Symptoms include nausea, abdominal pain, cramping, bloating, dehydration, fever, bloody stools, frequent urge to evacuate the bowels, and incontinence. Treatment includes medication and a healthy lifestyle. The Diarrhea Drugs in Development market research report provides an overview of the diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics...
-
Product Insights
Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Hepatic encephalopathy is a worsening of brain function that occurs when the liver is no longer able to remove toxic substances in the blood. Symptoms include disorientation, drowsiness or confusion, change in sleep patterns, slurred speech and agitation, excitement, or rarely occurring seizures. The predisposing factors include gastrointestinal bleeding, increased protein intake, renal dysfunction with azotemia, constipation, drugs, and hypoxia. The Hepatic encephalopathy drugs in development market report provides an overview of the Hepatic Encephalopathy pipeline landscape. The report provides...
-
Thematic Analysis
Microbiome – Targeted Therapeutics in Immunology – Thematic Research
The microbiome is considered the genetic material of all microorganisms existing in and on the human body. Although the primary site of aggregated microbes is in the gastrointestinal (tract, populations of microorganisms are also found on the surface of the skin as well as in the upper and lower respiratory tract. The microbiome-targeting therapeutics in immunology thematic research report will help you in developing and designing your in-licensing and out-licensing strategies, using a detailed overview of current deals and technologies...
-
Product Insights
Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatic Encephalopathy - Drugs in Development, 2021, provides an overview of the Hepatic Encephalopathy (Gastrointestinal) pipeline landscape. Hepatic encephalopathy is a worsening of brain function that occurs when the liver is no longer able to remove toxic substances in the blood. Symptoms include disorientation, drowsiness or confusion, change in sleep patterns, slurred speech and agitation, excitement, or seizures (occur rarely). The predisposing factors include gastrointestinal bleeding, increased protein intake, renal...
-
Thematic Analysis
Microbiome-Targeted Therapeutics in Immunology
Flares in gastrointestinal and dermatology indications are characterized by a shift in the proportion of bacterial species in either the gut or skin microbiome. This report focuses on the development of therapies targeting the skin microbiome for the treatment of acne, atopic dermatitis and psoriasis and on the development of therapies targeting the gut microbiome for the treatment of Crohn’s disease, ulcerative colitis, and irritable bowel syndrome.
-
Product Insights
Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2017" provides an overview of Clostridium difficile Infections (Clostridium difficile Associated Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Clostridium difficile Infections (Clostridium difficile Associated Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Sector Analysis
OpportunityAnalyzer: Clostridium difficile Infections – Opportunity Analysis and Forecasts to 2026
Clostridium difficile, a Gram-positive, spore-forming, toxin-producing, non-invasive, anaerobic bacterium, is the causative organism of C. difficile infection (CDI), which is commonly associated with colitis, as well as C. difficile-associated diarrhea (CDAD. CDIs begin with colonization of the intestinal tract with C. difficile through community-acquired or healthcare-associated means. Observed most frequently in healthcare settings, CDIs often occur when normal intestinal flora are disrupted by antibiotic administration, which can give C. difficile a competitive growth advantage if patients are exposed to the...
-
Product Insights
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2019" provides an overview of Clostridium difficile Infections (Clostridium difficile Associated Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Clostridium difficile Infections (Clostridium difficile Associated Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Thematic Analysis
Biotechnology – Thematic Research
At its core, biotechnology is harnessing biological and molecular systems to develop products and processes. This report focuses on the most important and fastest growing areas of biotechnology which are its application to health and medicine.